Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024Business Wire • 12 days agoArcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within...